SYREON ACADEMY

We provide high-quality training in health research, equipping professionals with the latest methodologies and insights. Our experts bring extensive teaching experience, contributing to MSc and PhD programs at leading universities worldwide.

For researchers, clinicians, public decision-makers, and representatives of the private healthcare sector—including pharmaceutical and medical device companies, innovators, start-ups, scale-ups, and their investors—who are involved or interested in evidence-based healthcare financing decisions. Syreon Academy will provide problem-based courses, where theories, concepts, and methods are illustrated through practical exercises.

SYREON RESEARCH INSTITUTE OFFERS

  • Health technology assessment
  • Health economic modelling
  • Strategic pharmaceutical pricing
  • Healthcare outcomes research
  • Epidemiology
  • Health system performance assessment
  • Biostatistics

Brochures of previous editions:

Training Program in Health Economics and Outcomes Research

Bucharest, 25 – 26 November 2025

For researchers, clinicians, public decision-makers, and representatives of the private healthcare sector—including pharmaceutical and medical device companies, innovators, start-ups, scale-ups, and their investors—who are involved or interested in evidence-based healthcare financing decisions. Syreon Academy will provide problem-based courses, where theories, concepts, and methods are illustrated through practical exercises.

Day 1

AI in the value assessment of health technologies with Zoltán Kaló PhD; Ákos Bernard Jóźwiak DVM, PhD;

Day 2

Use of Real-world Evidence in Policy Decisions with Zoltán Kaló PhD; Bertalan Németh PhD; László Nagy PhD;

Training program in health economics & outcomes research

Whom?

For researchers, clinicians and public decision-makers representatives of the private health care sector who are involved or interested in evidence-based health care financing decisions.

Why?

Due to limited health care resources the efficiency of health care financing has to be
improved in lower income European countries. Evidence informed pharmaceutical
pricing & reimbursement decisions are based on the assessment of clinical benefits,
economic value and affordability. Syreon Academy will provide problem-based courses;
theories, concepts, and methods will be illustrated with exercises